Gender differences of thromboembolic events in atrial fibrillation

American Journal of Cardiology

Volumn 117, Issue 6, 2016, Pages 1021-1027

  Cheng, Emily Y ^a   Kong, Melissa H ^a  

^a Silicon Valley Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; ESTROGEN THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; HYPERTHYROIDISM; INFORMATION RETRIEVAL; KIDNEY DYSFUNCTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOGENICITY; AGE DISTRIBUTION; CALIFORNIA; COMPLICATION; EVIDENCE BASED MEDICINE; HEART FAILURE; INCIDENCE; OBSERVATIONAL STUDY; RISK FACTOR; SEX RATIO; STROKE;

AGE DISTRIBUTION; ANTICOAGULANTS; ATRIAL FIBRILLATION; CALIFORNIA; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; OBSERVATIONAL STUDIES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84959432435     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.12.040     Document Type: Review

References (67)

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. S. Björck, B. Palaszewski, L. Friberg, and L. Bergfeldt Atrial fibrillation, stroke risk, and warfarin therapy revisited Stroke 44 2013 3103 3108
3. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study JAMA 271 1994 840 844
4. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications Arch Intern Med 155 1995 469 473
5. K.H. Humphries, C.R. Kerr, S.J. Connolly, G. Klein, J.A. Boone, M. Green, R. Sheldon, M. Talajic, P. Dorian, and D. Newman New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome Circulation 103 2001 2365 2370
6. A.S. Volgman, M.F. Manankil, D. Mookherjee, and R.G. Trohman Women with atrial fibrillation: greater risk, less attention Gend Med 6 2009 419 432
7. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
8. A.L. Bailey, D.C. Scantlebury, and S.S. Smyth Go Red for Women: thrombosis and anti-thrombotic therapy in women Arterioscler Thromb Vasc Biol 29 2009 284 288
9. E.L. Glader, B. Stegmayr, B. Norrving, A. Terént, K. Hulter-Åsberg, P.O. Wester, and K. Asplund Sex differences in management and outcome after stroke: a Swedish national perspective Stroke 34 2003 1970 1975
10. J. Roquer, A. Rodríguez-Campello, M. Gomis, A. Ois, J.E. Martínez-Rodríguez, E. Munteis, J.J. Conte, J. Montaner, and J.A. Sabín Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men J Neurol 253 2006 1484 1489
11. Stroke Prevention in Atrial Fibrillation Investigators Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
12. H. Inoue, and H. Atarashi Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation Am J Cardiol 86 2000 852 855
13. T.J. Wang, J.M. Massaro, D. Levy, R.S. Vasan, P.A. Wolf, R.B. D'Agostino, M.G. Larson, W.B. Kannel, and E.J. Benjamin A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study JAMA 290 2003 1049 1056
14. J. Friberg, H. Scharling, N. Gadsbøll, T. Truelsen, and G.B. Jensen Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study) Am J Cardiol 94 2004 889 894
15. N. Dagres, R. Nieuwlaat, P.E. Vardas, D. Andresen, S. Lévy, S. Cobbe, D.T. Kremastinos, G. Breithardt, D.V. Cokkinos, and H.J. Crijns Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe J Am Coll Cardiol 49 2007 572 577
16. D. Poli, E. Antonucci, E. Grifoni, R. Abbate, G.F. Gensini, and D. Prisco Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment Thromb Haemost 101 2009 938 942
17. A. Ruigómez, S. Johansson, M. Wallander, N. Edvardsson, and L.A. García Rodríguez Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis Int J Cardiol 136 2009 186 192
18. L.Y. Lin, C.H. Lee, C.C. Yu, C.T. Tsai, L.P. Lai, J.J. Hwang, P.C. Chen, and J.L. Lin Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-a nationwide database analysis Atherosclerosis 217 2011 292 295
19. J.B. Oleson, G.Y.H. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, J. Lindhardsen, C. Selmer, O. Ahlehoff, A.M. Olsen, G.H. Gislason, and C. Torp-Pedersen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
20. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y. Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
21. 2-VASc score of 0 or 1? Stroke 43 10 2012 2551 2555
22. L. Friberg, L. Benson, M. Rosenqvist, and G.Y.H. Lip Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study Br Med J 344 2012 e3522
23. A.P. Mikkelsen, J. Lindhardsen, G.Y. Lip, G.H. Gislason, C. Torp-Pedersen, and J.B. Oleson Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study J Thromb Haemost 10 2012 1745 1751
24. T.S. Potpara, J.M. Marinkovic, M.M. Polovina, G.R. Stankovic, P.M. Seferovic, M.C. Ostojic, and G.Y. Lip Gender-related differences in presentation, treatment, and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade Atrial Fibrillation Study Int J Cardiol 161 2012 39 44
25. M. Avgil Tsadok, C.A. Jackevicius, E. Rahme, K.H. Humphries, H. Behlouli, and L. Pilote Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation JAMA 307 2012 1952 1958
26. R.F. Bosch, D. Pittrow, A. Beltzer, I. Kruck, W. Kirch, A. Kohlhaussen, and H. Bonnemeier Gender differences in patients with atrial fibrillation Herzschrittmacherther Elektrophysiol 24 2013 176 183
27. M. Disertori, M.G. Franzosi, S. Barlera, F. Cosmi, S. Quintarelli, C. Favero, G. Cappellini, G. Fabbri, A.P. Maggioni, L. Staszewsky, L.A. Moroni, and R. Latini Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial BMC Cardiovasc Disord 13 2013 28
28. Y. Guo, H. Wang, X. Zhao, Y. Zhang, D. Zhang, J. Ma, Y. Wang, and G.Y. Lip Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation Int J Cardiol 168 2013 1502 1508
29. D. Poli, E. Antonucci, S. Testa, W. Ageno, and G. Palareti Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics) Thromb Res 131 2013 12 16
30. A.M. Salam, H.A. AlBinali, A.W. Al-Mulla, N. Asaad, R. Singh, A. Al-Qahtani, and J. Al Suwaidi Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991-2010) Int J Cardiol 168 2013 975 980
31. C.A. Aakre, C.J. McLeod, S.S. Cha, T.S. Tsang, G.Y. Lip, and B.J. Gersh Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation Stroke 45 2014 426 431
32. H. Inoue, H. Atarashi, K. Okumura, T. Yamashita, H. Origasa, N. Kumagai, M. Sakurai, Y. Kawamura, I. Kubota, K. Matsumoto, Y. Kaneko, S. Ogawa, Y. Aizawa, M. Chinushi, I. Kodama, E. Watanabe, Y. Koretsune, Y. Okuyama, A. Shimizu, O. Igawa, S. Bando, M. Fukatani, T. Saikawa, and A. Chishaki Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation Am J Cardiol 113 2014 957 962
33. G.R. Shroff, C.A. Solid, and C.A. Herzog Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010 JAHA 3 2014 e000756
34. C.W. Siu, G.Y.H. Lip, K.F. Lam, and H.F. Tse Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong Heart Rhythm 11 2014 1401 1408
35. Y.M. Yang, X.H. Shao, J. Zhu, H. Zhang, Y. Liu, X. Gao, L.S. Liu, L.T. Yu, L. Zhao, P.H. Yu, H. Zhang, Q. He, and X.D. Gu Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis Int J Cardiol 173 2014 242 247
36. M.C. Fang, D.E. Singer, Y. Chang, E.M. Hylek, L.E. Henault, N.G. Jensvold, and A.S. Go Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) study Circulation 112 2005 1687 1691
37. M. Gomberg-Maitland, N.K. Wenger, J. Feyzi, M. Lengyel, A.S. Volgman, P. Petersen, L. Frison, and J.L. Halperin Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials Eur Heart J 27 2006 1947 1953
38. R.G. Hart, L.A. Pearce, R. McBride, R.M. Rothbart, and R.W. Asinger Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III Clinical Trials Stroke 30 1999 1223 1229
39. R.M. Sullivan, J. Zhang, G. Zamba, G.Y.H. Lip, and B. Olshansky Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM) Am J Cardiol 110 2012 1799 1802
40. J. Mant, F.D.R. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, G.Y. Lip, and E. Murray Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial Lancet 370 2007 493 503
41. M. Rienstra, D.J. Van Veldhuisen, V.E. Hagens, A.V. Ranchor, N.J. Veeger, H.J. Crijns, and I.C. Van Gelder Gender-related differences in rhythm control treatment in persistent atrial fibrillation J Am Coll Cardiol 46 2005 1298 1306
42. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, and L. Wallentin Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
43. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, S. Golitsyn, G. Flaker, A. Avezum, S.H. Hohnloser, R. Diaz, M. Talajic, J. Zhu, P. Pais, A. Budaj, A. Parkhomenko, P. Jansky, P. Commerford, R.S. Tan, K.H. Sim, B.S. Lewis, W.V. Mieghem, G.Y.H. Lip, J.H. Kim, F. Lanas-Zanetti, A. Gonzalez-Hermosillo, A.L. Dans, M. Munawar, M. O'Donnell, J. Lawrence, G. Lewis, R. Afzal, and S. Yusuf Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
44. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, H.R. Al-Khalidi, J. Ansell, D. Atar, A. Avezum, M.C. Bahit, R. Diaz, J.D. Easton, J.A. Ezekowitz, G. Flaker, D. Garcia, M. Geraldes, B.J. Gersh, S. Golitsyn, S. Goto, A.G. Hermosillo, S.H. Hohnloser, J. Horowitz, P. Mohan, P. Jansky, B.S. Lewis, J.L. Lopez-Sendon, P. Pais, A. Parkhomenko, F.W. Verheugt, J. Zhu, and L. Wallentin Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
45. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, and R.M. Califf Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
46. A.J. Wagstaff, T.F. Overvad, G.Y. Lip, and D.A. Lane Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis QJM 107 2014 955 967
47. S.B. Pancholy, P.S. Sharma, D.S. Pancholy, T.M. Patel, D.J. Callans, and F.E. Marchlinski Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants Am J Cardiol 113 2014 485 490
48. I.E. Albertsen, L.H. Rasmussen, T.F. Overvad, T. Graungaard, T.B. Larsen, and G.Y. Lip Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis Stroke 44 2013 1329 1336
49. C. Madias, and R.G. Trohman The link between atrial fibrillation and stroke in women Womens Health (Lond Engl) 7 2011 375 382
50. R.G. Hart, J.W. Eikelboom, and L.A. Pearce Sex, stroke, and atrial fibrillation Arch Neurol 69 2012 1641 1643
51. R. Pisters, D.A. Lane, F. Marin, A.J. Camm, and G.Y. Lip Stroke and thromboembolism in atrial fibrillation: systematic review of stroke risk factors and risk stratification schema Circ J 76 2012 2289 2304
52. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke JAMA 285 2011 2864 2870
53. 2-VASc score, underuse of oral anticoagulation, and implications for preventive measures Eur J Neurol 20 2013 117 123
54. 2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? Am J Med 126 2013 1143 e1-8
55. D.A. Lane, and G.Y. Lip Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients Thromb Haemost 101 2009 802 805
56. J.J. Sheu, J.H. Kang, H.C. Lin, and H.C. Lin Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study Stroke 41 2010 961 966
57. S. Kaptoge, I.R. White, S.G. Thompson, and A.M. Wood Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the Fibrinogen Studies Collaboration Am J Epidemiol 166 2007 867 879
58. R.G. Wieberdink, M.C. van Schie, P.J. Koudstaal, A. Hofman, J.C. Witteman, M.P. de Maat, F.W. Leebeek, and M.M. Breteler High von Willebrand factor levels increase the risk of stroke: the Rotterdam Study Stroke 41 2010 2151 2156
59. D.S. Conway, J. Heeringa, D.A. Van Der Kuip, B.S. Chin, A. Hofman, J.C. Witteman, and G.Y. Lip Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study Stroke 34 2003 413 417
60. U. Rauch Gender differences in anticoagulation and antithrombotic therapy Handb Exp Pharmacol 214 2012 523 542
61. N.J. Breet, M.A. Sluman, M.A. van Berkel, J.W. van Werkum, H.J. Bouman, A.M. Harmsze, J.C. Kelder, F. Zijlstra, C.M. Hackeng, and J.M. Ten Berg Effect of gender difference on platelet reactivity Neth Heart J 19 2011 451 457
62. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359 364
63. M. Paquette, D. Roy, M. Talajic, D. Newman, A. Couturier, C. Yang, and P. Dorian Role of gender and personality on qualify-of-life impairment in intermittent atrial fibrillation Am J Cardiol 86 2000 764 768
64. G.Y. Lip, J. Eikelboom, S. Yusuf, O. Shestakovska, R.G. Hart, and S. Connolly Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES Study Stroke 45 2014 2127 2130
65. G.Y. Lip, C. Laroche, G. Boriani, P. Cimaglia, G.A. Dan, M. Santini, Z. Kalarus, L.H. Rasmussen, M.I. Popescu, O. Tica, C.F. Hellum, B. Mortensen, L. Tavazzi, and A.P. Maggioni Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation Europace 17 2015 24 31
66. P. Sabouret, L. Depret-Bixio, F.E. Cotte, P. Marie, N. Bedira, and P. Blin Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation in General Practice) database Clin Res Cardiol 103 2014 887 893
67. R.G. Hart, J.L. Halperin, L.A. Pearce, D.C. Anderson, R.A. Kronmal, R. McBride, E. Nasco, D.G. Sherman, R.L. Talbert, and J.R. Marler Lessons from the stroke prevention in atrial fibrillation trials Ann Intern Med 138 2008 831 838